User profiles for Tony M. Korman

Tony Korman

Monash Infectious Diseases, Monash Health, Monash University
Verified email at monash.edu
Cited by 9443

SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia

…, RJ Pierce, JG Armstrong, TM Korman… - Clinical infectious …, 2008 - academic.oup.com
Background . Existing severity assessment tools, such as the pneumonia severity index (PSI)
and CURB-65 (tool based on confusion, urea level, respiratory rate, blood pressure, and …

Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility

…, PB Ward, PGP Charles, TM Korman… - Clinical Infectious …, 2004 - academic.oup.com
Although infections caused by methicillin-resistant Staphylococcus aureus with reduced
vancomycin susceptibility (SA-RVS) have been reported from a number of countries, including …

Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia

…, MB Schultz, BP Howden, TM Korman… - Medical Journal of …, 2020 - Wiley Online Library
Objectives To describe the first isolation and sequencing of SARS ‐CoV‐2 in Australia and
rapid sharing of the isolate. Setting SARS ‐CoV‐2 was isolated from a 58‐year‐old man from …

Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

…, JO Robinson, TM Korman… - Journal of Infectious …, 2011 - academic.oup.com
(See the editorial commentary by Holland and Fowler Jr, on pages 329–31 .) Background.
There are concerns about reduced efficacy of vancomycin in patients with Staphylococcus …

The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy

…, R Stirling, AA Wright, TM Korman… - Clinical Infectious …, 2008 - academic.oup.com
Background . Available data on the etiology of community-acquired pneumonia (CAP) in
Australia are very limited. Local treatment guidelines promote the use of combination therapy …

Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis

…, A Deplano, R Patel, AR Larsen, TM Korman… - Nature …, 2018 - nature.com
Staphylococcus epidermidis is a conspicuous member of the human microbiome, widely
present on healthy skin. Here we show that S. epidermidis has also evolved to become a …

Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia

…, WJ Munckhof, JO Robinson, TM Korman… - Antimicrobial agents …, 2013 - Am Soc Microbiol
A ratio of the vancomycin area under the concentration-time curve to the MIC (AUC/MIC) of
≥400 has been associated with clinical success when treating Staphylococcus aureus …

[HTML][HTML] Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality

…, N Sherry, GC Taori, TM Crozier, GK Hart, TM Korman… - Critical Care, 2011 - Springer
Introduction To estimate the incidence of intensive care unit (ICU)-acquired bloodstream
infection (BSI) and its independent effect on hospital mortality. Methods We retrospectively …

Increasing tolerance of hospital Enterococcus faecium to handwash alcohols

…, EA Grabsch, D Kotsanas, TM Korman… - Science translational …, 2018 - science.org
Alcohol-based disinfectants and particularly hand rubs are a key way to control hospital
infections worldwide. Such disinfectants restrict transmission of pathogens, such as multidrug-…

Clinical Manifestations of Cryptococcus gattii Infection: Determinants of Neurological Sequelae and Death

…, B Currie, K Hajkowicz, TM Korman… - Clinical infectious …, 2012 - academic.oup.com
Background. Longer-term morbidity and outcomes of Cryptococcus gattii infection are not
described. We analyzed clinical, microbiological, and outcome data in Australian patients …